Clinical Trial Update: Nicotine Treatment of Impulsivity in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nicotine treatment for impulsivity in Parkinson's disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: University of Vermont | Conditions: Parkinson's Disease | Phase 4 | Status: UNKNOWN